Comments
Loading...
Radiopharm Theranostics Analyst Ratings and Price Targets | OTC:RDPTF | Benzinga
Radiopharm Theranostics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Radiopharm Theranostics Corp from these most-recent analyst ratings.
Analyst Ratings for Radiopharm Theranostics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Radiopharm Theranostics (RDPTF) stock?
There is no price target for Radiopharm Theranostics
What is the most recent analyst rating for Radiopharm Theranostics (RDPTF)?
There is no analyst for Radiopharm Theranostics
When was the last upgrade for Radiopharm Theranostics (RDPTF)?
There is no last upgrade for Radiopharm Theranostics
When was the last downgrade for Radiopharm Theranostics (RDPTF)?
There is no last downgrade for Radiopharm Theranostics.
When is the next analyst rating going to be posted or updated for Radiopharm Theranostics (RDPTF)?
There is no next analyst rating for Radiopharm Theranostics.
Is the Analyst Rating Radiopharm Theranostics (RDPTF) correct?
There is no next analyst rating for Radiopharm Theranostics.
Browse analyst ratings and price targets on all stocks.
